Neurology News and Research

Latest Neurology News and Research

Study underscores need for more targeted antidepressant therapies to decrease depressive symptoms

Even people who show a clear treatment response with antidepressant medications continue to experience symptoms like insomnia, sadness and decreased concentration, researchers at UT Southwestern Medical Center have found after analyzing data from the largest study on the treatment of depression.

21 Apr 2011

Early musical study may provide cognitive benefits as we age

Those childhood music lessons could pay off decades later - even for those who no longer play an instrument - by keeping the mind sharper as people age, according to a preliminary study published by the American Psychological Association.

21 Apr 2011

Brain trauma helped by nutrition

According to a report by the Institute of Medicine, military personnel who suffer traumatic brain injury need to be fed adequately and immediately to reduce the severity of trauma and improve their chance of survival. This finding has implications for people sustaining head injuries in other situations, such as sports and traffic accidents.

20 Apr 2011

Anavex: First-in-human dosing cmmenced in ANAVEX 2-73 clinical trial for Alzheimer’s

Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) today announced that the first healthy human volunteers have been initially dosed in its Phase I clinical trial to evaluate ANAVEX 2-73, the company’s lead compound for Alzheimer’s disease. “We are pleased that the first volunteers have been dosed with the study drug, according to the study protocol, and no adverse events have been recorded post dosing to date," said Dr. Ozkan Yalkinoglou, Medical Director of ABX-CRO.

20 Apr 2011

Quest Diagnostics first quarter revenues increase to $1.8 billion

Quest Diagnostics Incorporated, the world's leading provider of diagnostic testing, information and services, announced that for the first quarter ended March 31, 2011, adjusted income from continuing operations was $164 million, or $1.00 per diluted share, compared to $182 million, or $0.99 per diluted share in 2010.

From Quest Diagnostics 20 Apr 2011

Adeona, TG United enter commercial-scale manufacturing agreement for reaZin

Adeona Pharmaceuticals, Inc., a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement with TG United, Inc. of Brooksville, Florida, to provide commercial-scale manufacturing capabilities for reaZin. Adeona is developing reaZin, its product candidate for the dietary management of Alzheimer's disease and mild cognitive impairment, as a prescription medical food.

20 Apr 2011

Alzheimer’s diagnostic guidelines released

Neurologists and experts have come up with a set of guidelines to better diagnose Alzheimer's disease in the clinic for the first time in nearly three decades. The advice also helps doctors identify the earliest signs of the degenerative condition, even before symptoms of memory loss begin. The hope is that they can help patients prepare early, and eventually treat, the disease.

19 Apr 2011

Effects of obesity on the brain: first evidence of sex-related differences

...

19 Apr 2011

FDA approval of Pipeline Embolization Device offers better options for treatment of large/giant aneurysms

The recent U.S. Food and Drug Administration (FDA) approval of a brain aneurysm device has opened the door for neurosurgeons at Jefferson Hospital for Neuroscience (JHN) to offer advanced treatment to patients suffering from large or giant aneurysms who otherwise have limited, effective options.

19 Apr 2011

New biomarker-based test more effective for early acute kidney injury detection

A new biomarker-based diagnostic test is more effective than the current best practice for early detection of adverse outcomes after acute kidney injury, which can be fatal for an estimated 50 percent of the critically ill patients who get the condition.

19 Apr 2011

People with infectious mononucleosis, low UVB exposure may face high risk of MS

New research suggests that people who are exposed to low levels of sunlight coupled with a history of having a common virus known as mononucleosis may be at greater odds of developing multiple sclerosis than those without the virus.

19 Apr 2011

New study finds treatment-resistant epilepsy common in idiopathic autism

A new study found that treatment-resistant epilepsy (TRE) is common in idiopathic autism. Early age at the onset of seizures and delayed global development were associated with a higher frequency of resistance to antiepileptic drugs (AEDs). Full findings appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy (ILAE).

19 Apr 2011

Nerve disorder expert Jack Griffin passes away

Jack Griffin, an internationally acclaimed and admired expert on diseases of the peripheral nervous system, founding director of the Johns Hopkins Brain Science Institute, and former director of Hopkins School of Medicine's Department of Neurology, died Saturday, April 16, after a long battle with bladder cancer. He was 69.

18 Apr 2011

Ipsen, Active Biotech sign deal to co-develop and commercialize TASQ

Active Biotech AB and Ipsen announced today that they have entered into a broad partnership to co-develop and commercialize Active Biotech's investigational compound Tasquinimod "TASQ".

18 Apr 2011

Sarcasm and lie detection failure signals dementia: Study

Researchers have found that inability to recognize others' insincerity, lies and sarcasm could be a warning sign of a form of dementia. They found that people with frontotemporal dementia - a type of dementia that affects the frontal and temporal lobes of the brain - often lose the ability to detect sarcasm and lies, while people who grow older normally don't experience this.

17 Apr 2011

Person's inability to understand sarcasm and lies can be a warning sign of dementia

By asking a group of older adults to analyze videos of other people conversing -- some talking truthfully, some insincerely -- a group of scientists at the University of California, San Francisco has determined which areas of the brain govern a person's ability to detect sarcasm and lies.

16 Apr 2011

New book on women's health and diabetes care

"If there is anything that this disease has done to improve my life, it taught me at a young age how to take care of myself." - Nikki Peterson, 24 years old, diabetes for 14 years.

16 Apr 2011

Data of ImmunoCellular's lead dendritic cell cancer vaccine candidate for GBM presented at AAN meeting

ImmunoCellular Therapeutics, Ltd., announced that Surasak Phuphanich, MD, Principal Investigator of the Phase I clinical trial of ImmunoCellular's lead dendritic cell cancer vaccine candidate for glioblastoma multiforme presented safety and preliminary efficacy data yesterday at the American Academy of Neurology 63rd Annual Meeting.

16 Apr 2011

Opexa's Tovaxin Phase IIb study data in MS presented at AAN meeting

Opexa Therapeutics, Inc., a company developing Tovaxin, a novel T-cell therapy for multiple sclerosis, today presented important efficacy data at the American Academy of Neurology 63rd Annual Meeting.

16 Apr 2011

Patients with RLS more likely to develop cardiovascular conditions

Results from a two-year retrospective cohort study presented at the 63rd Annual Meeting of the American Academy of Neurology, Hawaii, U.S., showed that patients were significantly more likely to develop cardiovascular conditions, including hypertension, cardiac dysrhythmias and chronic ischemic heart diseases after an initial diagnosis of RLS, as compared to controls without RLS.

15 Apr 2011